AstraZeneca said on Monday that its hypertension pill baxdrostat had been approved in the United States, providing a new treatment option for millions of patients whose high blood pressure remains uncontrolled despite existing therapies.

A baby formula recall has raised fresh safety concerns for parents after U.S. regulators detected a toxin linked to vomiting in several batches of infant formula.

Hims & Hers Health’s attempt to launch a low-cost oral weight-loss pill has drawn swift regulatory and legal pushback, threatening the telehealth company’s next major growth strategy and intensifying scrutiny of drug compounders.

Shares of Danish pharmaceutical giant Novo Nordisk rebounded after U.S. regulators signaled plans to crack down on illegal copycat versions of approved medicines.

Novo Nordisk’s stock surged after the U.S. Food and Drug Administration approved the drugmaker’s weight-loss pill, giving the Danish company a boost in the competitive race to bring an effective oral obesity treatment to market and helping it regain momentum against rival Eli Lilly.

Novo Nordisk has won U.S. regulatory approval for its long-awaited weight-loss pill, marking a major milestone in the fast-growing obesity drug market and intensifying competition with rival Eli Lilly.

The listeria outbreak tied to prepared pasta meals has widened, with the U.S. Food and Drug Administration (FDA) reporting two additional deaths and seven new illnesses.

Replimune Group Inc (NASDAQ: REPL) saw its stock jump 60% after the U.S. Food and Drug Administration (FDA) accepted the company’s resubmission of a Biologics License Application (BLA) for its experimental melanoma treatment, RP1.

The U.S. Food and Drug Administration (FDA) has authorized Apple (AAPL.O) to launch a new hypertension detection feature on its smartwatches, the company said late Friday.